SAT-548 Variations in dynamic T cell response are associated with the HCC recurrence treated with anti-PD-1 immunotherapy after interventional therapy
Yonghong Zhang(Soochow University), Yu Sun(University of Pennsylvania), Kang Li(Second Hospital of Tianjin Medical University), Ling Qin(Central South University), Wenying Qiao(Capital Medical University), Tingting Mei, Biyu Liu, Jian‐Jun Li(Lianyungang Oriental Hospital), Yinghua Zhang(Beijing Automotive Group (China)), Chunwang Yuan(Capital Medical University), Chaoran Zang, Cai-Xia Hu(Capital Medical University)
Cited by 0
Related Papers
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)
|Signal Transduction and Targeted Therapy|2023|295
Refractive Error in Urban and Rural Adult Chinese in Beijing
|Ophthalmology|2005|273
YAP is a critical oncogene in human cholangiocarcinoma
|Oncotarget|2015|152
Central anorexigenic actions of bile acids are mediated by TGR5
|Nature Metabolism|2021|142
ULK1/2 Constitute a Bifurcate Node Controlling Glucose Metabolic Fluxes in Addition to Autophagy
|Molecular Cell|2016|130